Clinical Trials Sponsored by Harvard Lab for Economic Applications and Policy
Total 1 results
-
Harvard UniversityWeiss Family Program Fund for Research in Development Economics; Harvard Lab...Completed
Sponsors and Collaborators
- Prestige Biopharma Limited
- Grand Challenges Canada
- Bruce County Paramedic Service
- Centro di Procreazione Assistita Demetra
- North Karelia Hospital District
- Women and children's hospital of Jiaxing university
- ImproveCareNow (ICN)
- Mononuclear Therapeutics Ltd.
- Chengdu Nuoen Biotechnologies, Inc.
- Nestor Soler Porcar, MD, PhD
- Equipe MiMes
- Yantai Yuhuangding Hospital，Medical College, Qingdao University
- Reina Sofia University Hospital
- AIDS Council of New South Wales
- Maria Lendorf
- Bjørgene Omsorgssenter, Haugesund
- Veeda Oncology
- InflaRx GmbH
- BayCare Health System
- Neuregenix
- View Full List
Medical Conditions
- Endocarditis Infective
- Gullian Barre Syndrome
- Closure; Foramen Ovale
- Fracture Dislocation of Cervical Spine
- Multisystem Proteinopathy
- Epidemic Hemorrhagic Fever
- Tay-Sachs Disease Ganglioside
- Fetus or Neonate Affected by External Version Before Labor
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Chlamydophila Infections
- Psoriasis, Arthritic
- Painless Hysteroscopy
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Skull Base Neoplasms
- Predictors of Atrial Fibrillation Recurrences
- Childhood Langerhans Cell Histiocytosis
- Spine Surgeries
- Pulmonary Adenocarcinoma
- Ewing's Family Tumors
- View Full List
Drug Interventions
- Neihulizumab
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Azelastine hydrochloride (BAYR9258)
- Adapalene Gel 0.3%
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Esomeprazole 40mg before
- Qingkailing injection 40 ml
- Semapimod
- Vehicle
- Adriamycin
- Cereport
- Palliative care group first-line scheme
- Estradiol+Drospirenone
- EFV +TVA
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Redifferentiation with retinoid acid
- Glimepiride
- High dose pantoprazole infusion
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Chemotherapeutic Agent
- View Full List
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Austria
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Finland
- Contract Research Organizations in France
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Moldova
- Contract Research Organizations in Oman
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Philippines
- Contract Research Organizations in Poland
- Contract Research Organizations in South Africa
- Contract Research Organizations in Ukraine
- CRO list by country